Filtered By:
Specialty: Opthalmology
Drug: Dexamethasone
This page shows you your search results in order of date.
Order by Relevance | Date
Total 184 results found since Jan 2013.
Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration
CONCLUSIONS: Aprepitant X formulation is a promising candidate for the treatment of pain associated with inflammation of the ocular surface.PMID:37690516 | DOI:10.1016/j.jtos.2023.09.004
Source: The Ocular Surface - September 10, 2023 Category: Opthalmology Authors: Filippo Bonelli Ibrahim Demirsoy Romina Mayra Lasagni Vitar Philippe Fonteyne Giulio Ferrari Source Type: research
Resolution of Macular Edema secondary to rituximab after intravitreal dexamethasone: A case report and a review of the literature
CONCLUSIONS AND IMPORTANCE: ME is a rare complication after Rituximab infusions and very few cases are reported in the literature. Usually, ME occurs a few weeks after systemic administration and is probably related to a local release of cytokines. It resolves with oral, subtenon or intravitreal steroids. Our case is the first showing that IDI is a safe and effective treatment in ME secondary to Rituximab. Rituximab is not required to be discontinued if treatment for ME is started.PMID:37644808 | DOI:10.1177/11206721231199120
Source: European Journal of Ophthalmology - August 30, 2023 Category: Opthalmology Authors: Martina Maceroni Angelo Maria Minnella Source Type: research
Intravitreal dexamethasone to manage post endothelial keratoplasty cystoid macular oedema refractory to topical therapy
Eur J Ophthalmol. 2023 Aug 22:11206721231189120. doi: 10.1177/11206721231189120. Online ahead of print.NO ABSTRACTPMID:37605631 | DOI:10.1177/11206721231189120
Source: European Journal of Ophthalmology - August 22, 2023 Category: Opthalmology Authors: Nuno Moura-Coelho Renato Papa-Vettorazzi Jos é L Güell Source Type: research
